Neurology Editors’ Choice: Top Stories of 2015 los mejores estudios de neurología del 2015

 

Information sourced from NEJM Journal Watch:

Neurology Editors’ Choice: Top Stories of 2015

  1. Andrew Josephson, MD

A perspective on the most important research in the field from the past year

I am pleased to introduce this year’s NEJM Journal Watch Neurology Top Ten Stories of 2015. As in years past, I have made these selections after carefully reviewing all of the year’s summaries. In making the choices, I have tried to strike a balance between relevance to the clinician, recognition of landmark studies, and media publicity and public awareness. The sequence of stories is not intended to reflect their relative importance. I hope you find the list useful and thought-provoking.

The Neurology Top Stories of 2015, in no particular order, are:

Compelling Evidence That Modern Endovascular Therapy Improves Stroke Outcomes
[Berkhemer OA et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015 Jan 1; 372:11. Full-text NEJM article PDF | PubMed® abstract]

Symptoms of Parkinson Disease a Decade Before Diagnosis
[Schrag A et al. Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study. Lancet Neurol 2015 Jan; 14:57. Full-text Lancet Neurol article PDF | PubMed® abstract]

Barriers to Referral for Epilepsy Surgery Evaluation
[Roberts JI et al. Neurologists’ knowledge of and attitudes toward epilepsy surgery: A national survey. Neurology 2015 Jan 13; 84:159. Full-text Neurology article PDF in PubMed® Central |PubMed® abstract]

Neuropathic Pain Therapy: Evidence-Based Recommendations
[Finnerup NB et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol 2015 Feb; 14:162. PubMed® abstract]

Can Ineffective Acute Migraine Treatment Lead to Chronic Migraine?
[Lipton RB et al. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 2015 Feb 17; 84:688. PubMed® abstract]

Blood Biomarkers for Amyotrophic Lateral Sclerosis
[Lu C-H et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology 2015 Jun 2; 84:2247. Full-text Neurology article PDF in PubMed® Central | PubMed® abstract]

Is Status Epilepticus Becoming More Frequent?
[Betjemann JP et al. Trends in status epilepticus—related hospitalizations and mortality: Redefined in US practice over time.JAMA Neurol 2015 Jun; 72:650. PubMed® abstract]

Oral vs. Intravenous High-Dose Glucocorticoids for MS Relapses: Your Choice
[Le Page E et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): A randomised, controlled, double-blind, non-inferiority trial. Lancet 2015 Sep 5; 386:974. PubMed® abstract]

A Clinical Decision Tool for Patients with Cerebral Aneurysms
[Etminan N et al. The unruptured intracranial aneurysm treatment score: A multidisciplinary consensus. Neurology 2015 Sep 8; 85:881. Full-text Neurology article PDF in PubMed® Central |PubMed® abstract]

Is Multiple System Atrophy a Prion Disorder?
[Prusiner SB et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with Parkinsonism. Proc Natl Acad Sci U S A 2015 Sep 22; 112:E5308. PubMed® abstract]

NEJM Journal Watch is produced by NEJM Group, a division of the Massachusetts Medical Society. Copyright ©2016 Massachusetts Medical Society. All rights reserved.

The above message comes from NEJM Journal Watch, who is solely responsible for its content.

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *